{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:53:19Z","timestamp":1788043999052,"version":"build-2784847793"},"reference-count":56,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15172","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T08:15:45Z","timestamp":1751616945000},"page":"1-11","source":"Crossref","is-referenced-by-count":2,"title":["Silymarin induces multiple myeloma cell apoptosis by inhibiting the JAK2\/STAT3 signaling pathway"],"prefix":"10.3892","volume":"30","author":[{"given":"Haiyun","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nangchang, Jiangxi 330000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nangchang, Jiangxi 330000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junquan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Jinggangshan University, Ji'an, Jiangxi 343000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nangchang, Jiangxi 330000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"key20250812093609_b1-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"key":"key20250812093609_b2-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: A review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"key20250812093609_b3-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"926","DOI":"10.4143\/crt.2021.951","article-title":"Association between kidney function, proteinuria and the risk of multiple myeloma: A population-based retrospective cohort study in South Korea","volume":"54","author":"Choi","year":"2022","journal-title":"Cancer Res Treat"},{"key":"key20250812093609_b4-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1681\/ASN.2006020139","article-title":"Multiple myeloma","volume":"17","author":"Korbet","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key20250812093609_b5-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ajh.24236","article-title":"Myeloma today: Disease definitions and treatment advances","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Am J Hematol"},{"key":"key20250812093609_b6-ol-30-3-15172","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13083","article-title":"Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival","author":"Turesson","year":"2018","journal-title":"Eur J Haematol"},{"key":"key20250812093609_b7-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"key20250812093609_b8-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"7591","DOI":"10.1080\/10408398.2021.1915745","article-title":"The role and mechanism of citrus flavonoids in cardiovascular diseases prevention and treatment","volume":"62","author":"Deng","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"key20250812093609_b9-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1389557522666220602141142","article-title":"Salahuddin: An insight into the hepatoprotective activity and structure-activity relationships of flavonoids","volume":"23","author":"Majee","year":"2023","journal-title":"Mini Rev Med Chem"},{"key":"key20250812093609_b10-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1002\/ptr.8173","article-title":"Effects of silymarin supplementation on liver and kidney functions: A systematic review and dose-response meta-analysis","volume":"38","author":"Mohammadi","year":"2024","journal-title":"Phytother Res"},{"key":"key20250812093609_b11-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","article-title":"Silymarin as supportive treatment in liver diseases: A narrative review","volume":"37","author":"Gillessen","year":"2020","journal-title":"Adv Ther"},{"key":"key20250812093609_b12-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.3390\/molecules27165327","article-title":"Mechanistic insights into the pharmacological significance of silymarin","volume":"27","author":"Wadhwa","year":"2022","journal-title":"Molecules"},{"key":"key20250812093609_b13-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3390\/molecules25092009","article-title":"Silymarin and cancer: A dual strategy in both in chemoprevention and chemosensitivity","volume":"25","author":"Delmas","year":"2020","journal-title":"Molecules"},{"key":"key20250812093609_b14-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"2515690X211068826","DOI":"10.1177\/2515690X211068826","article-title":"Role of silymarin in cancer treatment: Facts, hypotheses, and questions","volume":"27","author":"Koltai","year":"2022","journal-title":"J Evid Based Integr Med"},{"key":"key20250812093609_b15-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.3892\/mmr.2016.4887","article-title":"Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K\/Akt\/mTOR signaling pathway","volume":"13","author":"Feng","year":"2016","journal-title":"Mol Med Rep"},{"issue":"D1","key":"key20250812093609_b16-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: The universal protein knowledgebase in 2025","volume":"53","author":"UniProt","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"key20250812093609_b17-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D1056","DOI":"10.1093\/nar\/gky1133","article-title":"Open targets platform: New developments and updates two years on","volume":"47","author":"Carvalho-Silva","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"key20250812093609_b18-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.csbj.2021.05.015","article-title":"The DisGeNET cytoscape app: Exploring and visualizing disease genomics data","volume":"19","author":"Pi\u00f1ero","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"D1","key":"key20250812093609_b19-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gky868","article-title":"The comparative toxicogenomics database: Update 2019","volume":"47","author":"Davis","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"key20250812093609_b20-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"baq020","DOI":"10.1093\/database\/baq020","article-title":"GeneCards version 3: The human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database (Oxford)"},{"key":"key20250812093609_b21-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: Database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"key20250812093609_b22-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"D1","key":"key20250812093609_b23-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"key20250812093609_b24-ol-30-3-15172","first-page":"27","article-title":"Protein-protein interaction analysis of Alzheimer's disease and NAFLD based on systems biology methods unhide common ancestor pathways","volume":"11","author":"Karbalaei","year":"2018","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"key20250812093609_b25-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","article-title":"Computing topological parameters of biological networks","volume":"24","author":"Assenov","year":"2008","journal-title":"Bioinformatics"},{"key":"key20250812093609_b26-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"key20250812093609_b27-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"D1","key":"key20250812093609_b28-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"key20250812093609_b29-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J Cheminform"},{"key":"key20250812093609_b30-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"2050009","DOI":"10.1142\/S0219720020500092","article-title":"PDB-2-PBv3.0: An updated protein block database","volume":"18","author":"Karuppasamy","year":"2020","journal-title":"J Bioinform Comput Biol"},{"key":"key20250812093609_b31-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jep.2018.12.033","article-title":"Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy","volume":"233","author":"Li","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"key20250812093609_b32-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"e43918","DOI":"10.1371\/journal.pone.0043918","article-title":"A system-level investigation into the mechanisms of Chinese traditional medicine: Compound danshen formula for cardiovascular disease treatment","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"key20250812093609_b33-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"bbad518","DOI":"10.1093\/bib\/bbad518","article-title":"Network pharmacology: Towards the artificial intelligence-based precision traditional Chinese medicine","volume":"25","author":"Zhang","year":"2023","journal-title":"Brief Bioinform"},{"key":"key20250812093609_b34-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: From bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"key20250812093609_b35-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: Lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"key20250812093609_b36-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semcancer.2018.01.018","article-title":"FOXO family in regulating cancer and metabolism","volume":"50","author":"Ma","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"key20250812093609_b37-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ctrv.2015.04.008","article-title":"Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy","volume":"41","author":"Bosch-Barrera","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"key20250812093609_b38-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.2174\/1871520618666180905154949","article-title":"Silimarin and cancer","volume":"18","author":"Liakopoulou","year":"2018","journal-title":"Anticancer Agents Med Chem"},{"key":"key20250812093609_b39-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3892\/ol.2021.12753","article-title":"Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis","volume":"21","author":"Kim","year":"2021","journal-title":"Oncol Lett"},{"key":"key20250812093609_b40-ol-30-3-15172","first-page":"4521","article-title":"Silymarin suppresses proliferation of human hepatocellular carcinoma cells under hypoxia through downregulation of the HIF-1\u03b1\/VEGF pathway","volume":"15","author":"Yu","year":"2023","journal-title":"Am J Transl Res"},{"key":"key20250812093609_b41-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1242\/dev.079046","article-title":"JAK\/STAT autocontrol of ligand-producing cell number through apoptosis","volume":"140","author":"Borensztejn","year":"2013","journal-title":"Development"},{"key":"key20250812093609_b42-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/10428199809058353","article-title":"The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation","volume":"28","author":"Weber-Nordt","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"key20250812093609_b43-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2003-06-2151","article-title":"Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis","volume":"103","author":"Bharti","year":"2004","journal-title":"Blood"},{"key":"key20250812093609_b44-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1593\/neo.04571","article-title":"Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth","volume":"7","author":"Corvinus","year":"2005","journal-title":"Neoplasia"},{"key":"key20250812093609_b45-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20250812093609_b46-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.lfs.2018.11.037","article-title":"Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation","volume":"217","author":"Shi","year":"2019","journal-title":"Life Sci"},{"key":"key20250812093609_b47-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ptr.6361","article-title":"Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review","volume":"33","author":"Soleimani","year":"2019","journal-title":"Phytother Res"},{"key":"key20250812093609_b48-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","article-title":"TargetNet: A web service for predicting potential drug-target interaction profiling via multi-target SAR models","volume":"30","author":"Yao","year":"2016","journal-title":"J Comput Aided Mol Des"},{"issue":"(Web Server Issue)","key":"key20250812093609_b49-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: A web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key20250812093609_b50-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13321-018-0325-4","article-title":"Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery","volume":"11","author":"Bosc","year":"2019","journal-title":"J Cheminform"},{"key":"key20250812093609_b51-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"21146","DOI":"10.1038\/srep21146","article-title":"BATMAN-TCM: A bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"issue":"D1","key":"key20250812093609_b52-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: Augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"key20250812093609_b53-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"key20250812093609_b54-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D1031","DOI":"10.1093\/nar\/gkz981","article-title":"Therapeutic target database 2020: Enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"key20250812093609_b55-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"key20250812093609_b56-ol-30-3-15172","doi-asserted-by":"publisher","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","article-title":"Comparative toxicogenomics database (CTD): Update 2023","volume":"51","author":"Davis","year":"2023","journal-title":"Nucleic Acids Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:36:17Z","timestamp":1754980577000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,4]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15172","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}